Todd D. Hatajik
Todd D. Hatajik is a scientist at Pfizer Global Research and Development (Groton, CT).
Articles
Available Guidance and Best Practices for Conducting Forced Degradation Studies
Dan W. Reynolds, PhD;Karen M. Alsante, PhD;Kevin L. Facchine, PhD;June F. Mullaney, PhD;Michael G. Motto, PhD;Todd D. Hatajik
February 1st 2002Participants at a Pharmaceutical Research and Manufacturers of America workshop share their views about the acceptable analytical practices of conducting forced degradation studies.
Latest Updated Articles
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
Published: September 10th 2024 | Updated: September 18th 2024
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
Published: October 28th 2024 | Updated: November 22nd 2024
Discovery to Commercialization: The Right Partnerships are Key to Streamlined Drug Development
Published: November 6th 2024 | Updated: November 22nd 2024
Automate Aseptic Filling: Closing the System at Full Modularity
Published: November 5th 2024 | Updated: November 22nd 2024
Untethered Data: Unifying and Contextualizing Drug Discovery Data
Published: November 8th 2024 | Updated: November 22nd 2024
Application of Validation Principles to the Training Quality System: Part 9, Quality Risk Management Hazard Identification
